mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
書誌事項
- 公開日
- 2019-05
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- http://creativecommons.org/licenses/by-nc-nd/4.0/
- DOI
-
- 10.1016/j.vaccine.2019.04.074
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Vaccine
-
Vaccine 37 (25), 3326-3334, 2019-05
Elsevier BV
